Cover Image
市場調查報告書

美國的人工骨替代材料市場:2011年∼2021年

US Market for Bone Graft Substitutes 2011-2021

出版商 iData Research Inc. 商品編碼 227848
出版日期 內容資訊 英文 132 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
美國的人工骨替代材料市場:2011年∼2021年 US Market for Bone Graft Substitutes 2011-2021
出版日期: 2015年06月01日 內容資訊: 英文 132 Pages
簡介

本報告提供美國的人工骨替代材料市場相關調查分析、市場概要、市場分析與預測、推動因素、阻礙因素 、競爭分析相關的系統性資訊。

第1章 調查手法

第2章 整形外科人工骨替代材料市場

  • 簡介
  • 市場區隔
  • 治療數
  • 市場概要
  • 市場分析與預測
  • 推動因素、阻礙因素
  • 競爭分析

簡稱集

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: iDATA_USBGS15_RPT

The bone graft substitute market consists of allograft, demineralized bone matrix and synthetic materials. Bone grafts are used in a variety of indications including spinal fusion, trauma, large joint reconstruction, foot reconstruction, as well as craniomaxillofacial and oncological applications.

The bone graft substitute market competes with both the growth factor market, which is currently only comprises INFUSE®, and the stem cell graft market. Due to the declining usage of INFUSE®, the use of bone graft substitute use has increased. The rise of cell therapy products, including platelet-rich-plasma and bone marrow concentrate, has also aided the growth of the bone graft substitute market, especially in the segments for demineralized bone matrices and synthetic grafts. Platelet-rich plasma provides growth factors when a graft is soaked in it; bone marrow concentrate provides stem cells. This complementary use allows bone graft substitutes to better compete with the growth factors and stem cell grafts.

Table of Contents

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

RESEARCH METHODOLOGY

  • 1.1 RESEARCH SCOPE
  • 1.2 IDATA'S 9-STEP METHODOLOGY
    • Step 1: Project Initiation & Team Selection
    • Step 2: Prepare Data Systems and Perform Secondary Research
    • Step 3: Preparation for Interviews & Questionnaire Design
    • Step 4: Performing Primary Research
    • Step 5: Research Analysis: Establishing Baseline Estimates
    • Step 6: Market Forecast and Analysis
    • Step 7: Identify Strategic Opportunities
    • Step 8: Final Review and Market Release
    • Step 9: Customer Feedback and Market Monitoring

ORTHOPEDIC BONE GRAFT SUBSTITUTE MARKET

  • 2.1 INTRODUCTION
  • 2.2 MARKET SEGMENTATION
    • 2.2.1 By Indication
      • 2.2.1.1 Spine
      • 2.2.1.2 Trauma
      • 2.2.1.3 Large Joint
      • 2.2.1.4 Foot Reconstruction
      • 2.2.1.5 Craniomaxillofacial
      • 2.2.1.6 Oncology
    • 2.2.2 By Material
      • 2.2.2.1 Autograft
      • 2.2.2.2 Standard Allograft
      • 2.2.2.3 Demineralized Bone Matrix
      • 2.2.2.4 Synthetic
      • 2.2.2.5 Xenograft
  • 2.3 PROCEDURE NUMBERS
    • 2.3.1 Bone Graft Substitutes Procedure Numbers by Material
    • 2.3.2 Units Per Procedure by Indication
  • 2.4 MARKET OVERVIEW
    • 2.4.1 Bone Graft Substitute Market by Material
    • 2.4.2 Bone Graft Substitute Market by Indication
  • 2.5 MARKET ANALYSIS AND FORECAST
    • 2.5.1 Total Orthopedic Bone Graft Substitute Market
    • 2.5.2 Bone Graft Substitute Market by Material
      • 2.5.2.1 Total Allograft Bone Graft Substitute Market
      • 2.5.2.2 Allograft Bone Graft Substitute Market by Indication
        • 2.5.2.2.1 Spine
          • 2.5.2.2.1.1 Cervical Spine
          • 2.5.2.2.1.2 Thoracolumbar Spine
        • 2.5.2.2.2 Trauma
          • 2.5.2.2.2.1 Non-union Trauma
          • 2.5.2.2.2.2 Fresh Fracture Trauma
        • 2.5.2.2.3 Large Joint Reconstruction
          • 2.5.2.2.3.1 Hip Large Joint Reconstruction
          • 2.5.2.2.3.2 Knee Large Joint Reconstruction
        • 2.5.2.2.4 Foot Reconstruction
        • 2.5.2.2.5 Craniomaxillofacial
        • 2.5.2.2.6 Oncology
      • 2.5.2.3 Total Demineralized Bone Matrix Market
      • 2.5.2.4 Demineralized Bone Matrix Market, with and without Carriers
      • 2.5.2.5 Demineralized Bone Matrix Market by Indication
        • 2.5.2.5.1 Spine
          • 2.5.2.5.1.1 Cervical Spine
          • 2.5.2.5.1.2 Thoracolumbar Spine
        • 2.5.2.5.2 Trauma
          • 2.5.2.5.2.1 Non-union Trauma
          • 2.5.2.5.2.2 Fresh Fracture Trauma
        • 2.5.2.5.3 Large Joint Reconstruction
          • 2.5.2.5.3.1 Hip Large Joint Reconstruction
          • 2.5.2.5.3.2 Knee Large Joint Reconstruction
        • 2.5.2.5.4 Foot Reconstruction
        • 2.5.2.5.5 Craniomaxillofacial
        • 2.5.2.5.6 Oncology
      • 2.5.2.6 Total Synthetic Bone Graft Substitute Market
      • 2.5.2.7 Synthetic Bone Graft Substitute Market by Indication
        • 2.5.2.7.1 Spine
          • 2.5.2.7.1.1 Cervical Spine
          • 2.5.2.7.1.2 Thoracolumbar Spine
        • 2.5.2.7.2 Trauma
          • 2.5.2.7.2.1 Non-union Trauma
          • 2.5.2.7.2.2 Fresh Fracture Trauma
        • 2.5.2.7.3 Large Joint Reconstruction
          • 2.5.2.7.3.1 Hip Large Joint Reconstruction
          • 2.5.2.7.3.2 Knee Large Joint Reconstruction
        • 2.5.2.7.4 Foot Reconstruction
        • 2.5.2.7.5 Craniomaxillofacial
        • 2.5.2.7.6 Oncology
    • 2.5.3 Bone Graft Substitute Market by Indication
      • 2.5.3.1 Spine Bone Graft Substitute Market
        • 2.5.3.1.1 Cervical Spine Bone Graft Substitute Market
        • 2.5.3.1.2 Thoracolumbar Spine Bone Graft Substitute Market
      • 2.5.3.2 Trauma Bone Graft Substitute Market
        • 2.5.3.2.1 Non-union Trauma Fracture Bone Graft Substitute Market
        • 2.5.3.2.2 Fresh Fracture Trauma Bone Graft Substitute Market
      • 2.5.3.3 Large Joint Reconstruction Bone Graft Substitute Market
        • 2.5.3.3.1 Hip Large Joint Reconstruction Bone Graft Substitute Market
        • 2.5.3.3.2 Knee Large Joint Reconstruction Bone Graft Substitute Market
      • 2.5.3.4 Foot Reconstruction Bone Graft Substitute Market
      • 2.5.3.5 Craniomaxillofacial Bone Graft Substitute Market
      • 2.5.3.6 Oncology Bone Graft Substitute Market
  • 2.6 DRIVERS AND LIMITERS
    • 2.6.1 Market Drivers
      • 2.6.1.1 Allograft Bone Graft Substitute Market
      • 2.6.1.2 Demineralized Bone Matrix Bone Graft Substitute Market
      • 2.6.1.3 Synthetic Bone Graft Substitute Market
    • 2.6.2 Market Limiters
      • 2.6.2.1 Allograft Bone Graft Substitute Market
      • 2.6.2.2 Demineralized Bone Matrix Bone Graft Substitute Market
      • 2.6.2.3 Synthetic Bone Graft Substitute Market
  • 2.7 COMPETITIVE ANALYSIS

ABBREVIATIONS

Back to Top